Jorge E Gomez, MD

img_Jorge E Gomez
ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Are you a patient?
Specialties
Internal Medicine, Cancer (Oncology)

MD, Universidad de Caldas

Residency, Internal Medicine, Pennsylvania Hospital

Fellowship, Hematology & Oncology, New York University School of Medicine

Certifications

American Board of Internal Medicine
Publications

Selected Publications

Surgical outcomes and quality of life in octogenarians with early-stage non-small cell lung cancer: a prospective cohort study. Louis Gros, Rowena Yip, Wenchao Ma, Jeffrey Zhu, Jiafang Zhang, Sydney Kantor, Siyang Cai, Andrew J. Kaufman, Andrea S. Wolf, Ardeshir Hakami-Kermani, Daniel Nicastri, Dong Seok Lee, Kimberly J. Song, Brian Housman, David F. Yankelevitz, Emanuela Taioli, Claudia I. Henschke, Raja M. Flores, Raja Flores, Andrew J. Kaufman, Dong Seok Daniel Lee, Daniel Nicastri, Andrea Wolf, Kimberly Song, Kenneth Rosenzweig, Robert Samstein, Pinaki Dutta, Jorge Gomez, Mary Beth Beasley, Maureen Zakowski, Michael Chung, David F. Yankelevitz, Claudia I. Henschke, Emanuela Taioli, Yeqing Zhu, Natela Paksashvili, Lijing Zhang, Lyu Lyu, Huiwen Chan, Jeffrey Zhu, Sydney Kantor, Lauren Lentini, Daniel Nicastri, Ardeshir Hakami-Kermani, Arzu Buyuk, Ardeshir Hakami-Kermani, Raja Flores, Emanuela Taioli, Rebecca Schwartz, Artit Jirapatnakul. The Lancet Regional Health - Americas

Phase 1/1b study of direct intratumoral injection of pleural mesothelioma of immunostimulant prior to surgical resection. Andrea S. Wolf, Shubham Gulati, Komal Dolasia, Bailey Fitzgerald, Jorge Gomez, David Yankelevitz, Andres Salazar, Alexander M. Tsankov, Thomas Marron, Raja Flores. Journal of Thoracic and Cardiovascular Surgery

Antibody drugs conjugates in non–small cell lung cancer: current status and challenges. Arjun Syal, May Lucie Meyer, Kenneth Angelino, Noah Osei, Jorge E. Gomez, Triparna Sen, Fred R. Hirsch. Oncologist

View All Publications

Jorge Gomez, MD

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Gomez during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Nuvation Bio
  • Lilly USA, LLC
  • Regeneron Pharmaceuticals, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.